ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 153325 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 153325; 2) Community: the network communities that were significantly associated with the response to NSC 153325; 3) Molecule: the relationships between components within communities and NSC 153325; 4) MDR: the compounds that were significantly associated with the NSC 153325.

NSC Compound Enrichment Correlation
NSC 92954 Card-20(22)-enolide, 3-(acetyloxy)-5,14-dihydroxy-19-oxo-, (3.beta.,5.beta.)- (9CI) 0.04831289866584 0.14755781
NSC 100880 Camptothecin 0.0490935610249067 -0.040514277
NSC 114346 Null 0.0490935610249067 0.19651146
NSC 13151 Null 0.0490935610249067 0.26105146
NSC 300289 Pinafide 0.049093561024907 -0.05854625
NSC 303861 L-Cysteine analog 0.049093561024907 0.28626031
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.049093561024907 0.36541774
NSC 30915 Null 0.049093561024907 0.36197347
NSC 371777 Null 0.049093561024907 0.17779695
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.049093561024907 0.31465359
Total:84  Current:80    [First] [Prev] [Next] [Last]